Patient info Open main menu

Cerelle 75 micrograms film-coated tablets – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
75 micrograms
Contains active substance:

Patient leaflet - Cerelle 75 micrograms film-coated tablets

1. WHAT CERELLE IS AND WHAT IT IS USED FOR

This medicine is for the prevention of pregnancy.

How does it work?

Cerelle contains a small amount of one type of female sex hormone, the progestogen, desogestrel. For this reason, Cerelle is called a progestogen-only pill (POP) or mini-pill. Unlike the combined pill, the POP or mini-pill does not contain an oestrogen hormone, but only a progestogen. Most POPs or mini-pills work primarily by preventing the sperm cells from entering the womb but they do not always prevent the egg cell from ripening which is the primarily action of combined pills.

Cerelle is distinct from other mini-pills in having a dose that in most cases is high enough to prevent the egg cell from ripening. As a result, Cerelle provides high contraceptive efficacy.

In contrast to the combined pill, Cerelle can be used by women who do not tolerate oestrogens and by women who are breast-feeding. A disadvantage is that vaginal bleeding may occur at irregular intervals during the use of Cerelle. You also may not have any bleeding at all.

2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE CERELLE

Cerelle will not protect you against HIV infection (AIDS) and any other sexually transmitted diseases.

Do not take Cerelle

Do not use Cerelle if you have any of the conditions listed below. If any of these apply to you, tell your doctor before starting to use Cerelle. Your doctor may advise you to use a non-hormonal method of birth control.

  • If you are allergic to desogestrel or any of the other ingredients of this medicine (listed in section 6.). – If you have thrombosis. Thrombosis is the formation of a blood clot in a blood vessel, which may lead to obstruction of this blood vessel {e.g. of the legs (deep venous thrombosis), the lungs (pulmonary embolism), the heart (heart attack) or brain (stroke)}.
  • If you have or have had jaundice (yellowing of the skin or whites of the eyes) or a severe liver disease and the function of your liver (as determined by laboratory investigation of the blood) has not returned to normal.
  • If you have or if you are suspected of having cancer that grows under the influence of certain hormones (progestagens), such as certain types of breast cancer. – If you have meningioma or have ever been diagnosed with a meningioma (a tumour of the tissue layer surrounding the brain and spinal cord that is usually benign). See section Warnings and precautions.
  • If you have any unexplained vaginal bleeding.

If any of these conditions appears for the first time while using Cerelle you should consult your doctor promptly.

Warnings and precautions

Talk to your doctor or pharmacist before taking Cerelle.

If any of these apply to you, tell your doctor before starting to use Cerelle:

  • you have or have ever had breast cancer;
  • you have cancer of the liver;
  • you have or ever had thrombosis (blockage of a blood vessel due to a blood clot);
  • you have diabetes;
  • you suffer from epilepsy (see section “Other medicines and Cerelle”);
  • you suffer from tuberculosis (see section “Other medicines and Cerelle”);
  • you have high blood pressure;
  • you have or have had chloasma (yellowish-brown pigmentation patches on the skin, particularly of the face); if so avoid too much exposure to the sun or ultraviolet radiation;
  • you have depression or mood changes.

If Cerelle is used in the presence of any of the conditions listed above, you may need to be kept under close observation. Your doctor can explain to you what to do.

Breast cancer

It is important to check your breasts regularly and contact your doctor as soon as possible if you feel any lump in your breasts.

Breast cancer has been found slightly more often in women who take the Pill than in women of the same age who do not take the Pill. If women stop taking the Pill, the risk gradually decreases, so that 10 years after stopping the Pill the risk is the same as for women who have never taken the Pill. Breast cancer is rare under 40 years of age but the risk increases as the woman gets older. Therefore, the extra number of breast cancers diagnosed is higher if the age until which the woman continues to take the Pill is higher. How long she takes the Pill is less important.

  • In every 10 000 women who take the Pill for up to 5 years but stop taking it by the age of 20, there would be less than 1 extra case of breast cancer found up to 10 years after stopping, in addition to the 4 cases normally diagnosed in this age group.
  • In 10 000 women who take the Pill for up to 5 years but stop taking it by the age of 30, there would be 5 extra cases in addition to the 44 cases normally diagnosed.
  • In 10 000 women who take the Pill for up to 5 years but stop taking it by the age of 40, there would be 20 extra cases in addition to the 160 cases normally diagnosed.

The risk of breast cancer in users of progestogen-only pills like Cerelle is believed to be similar to that in women who use the Pill, but the evidence is less conclusive.

Breast cancers found in women who take the Pill, seem less likely to have spread than breast cancers found in women who do not take the Pill. It is not known whether the difference in breast cancer risk is caused by the Pill. It may be that the women were examined more often, so that the breast cancer is noticed earlier.

Meningiomas

Use of desogestrel has been linked to a small increased risk for tumours of the tissue surrounding the brain and spinal cord that are usually benign (meningiomas). The risk appears to increase with longer use and in women who have previously used progestogens associated with meningioma. Overall, about one additional case of meningioma is estimated to occur for every 67,300 women treated with desogestrel. If you are diagnosed with meningioma, your doctor will stop treatment with Cerelle (see section ‘Do not take Cerelle’). If you notice any symptoms such as changes in vision (e.g. double vision or blurred vision), hearing loss or ringing in the ears, loss of smell, headaches that get worse over time, memory loss, seizures, or weakness in your arms or legs you must tell your doctor straight away.

Thrombosis

See your doctor immediately, if you notice possible signs of a thrombosis (see also ‘Contact your doctor as soon as possible if’).

Thrombosis is the formation of a blood clot, which may block a blood vessel. A thrombosis sometimes occurs in the deep veins of the legs (deep venous thrombosis). If this clot breaks away from the veins where it is formed, it may reach and block the arteries of the lungs, causing a so-called “pulmonary embolism”. A pulmonary embolism can cause chest pain, breathlessness, collapse or even death.

Deep venous thrombosis is a rare occurrence. It can develop whether or not you are taking the Pill. It can also happen if you become pregnant.

The risk is higher in Pill-users than in non-users. The risk with progestogen-only pills like Cerelle is believed to be lower than in users of Pills that also contain oestrogens (combined Pills).

Psychiatric disorders

Some women using hormonal contraceptives including Cerelle have reported depression or depressed mood. Depression can be serious and may sometimes lead to suicidal thoughts. If you experience mood changes and depressive symptoms contact your doctor for further medical advice as soon as possible.

Children and adolescents

The safety and efficacy of desogestrel in adolescents below 18 years has not yet been established. No data are available.

Other medicines and Cerelle

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

Also tell any other doctor or dentist who prescribes another medicine (or your pharmacist) that you take Cerelle. They can tell you if you need to take additional contraceptive precautions (for example condoms) and if so, for how long or whether the use of another medicine you need must be changed.

Some medicines:

  • can have an influence on the blood levels of Cerelle. – can make it less effective in preventing pregnancy. – can cause unexpected bleeding.

These include medicines used for the treatment of: – epilepsy (e.g. primidone, phenytoin, carbamazepine, oxcarbazepine, felbamate, topiramate and phenobarbital); – tuberculosis (e.g. rifampicin, rifabutin);

  • HIV infections (e.g. ritonavir, nelfinavir, nevirapine, efavirenz); – Hepatitis C virus infection (e.g. boceprevir, telaprevir); – or other infectious diseases (e.g. griseofulvin);
  • high blood pressure in the blood vessels of the lungs (bosentan); – depressive moods (the herbal remedy St. John’s Wort); – certain bacterial infections (e.g. clarithromycin, erythromycin); – fungal infections (e.g. ketoconazole, itraconazole, fluconazole);
  • high blood pressure (hypertension), angina or certain heart rhythm disorders (e.g. diltiazem).

If you are taking medicines or herbal products that might make Cerelle less effective, a barrier contraceptive method should also be used. Since the effect of another medicine on Cerelle may last up to 28 days after stopping the medicine, it is necessary to use the additional barrier contraceptive method for that long. Your doctor can tell you if you need to take additional contraceptive precautions and if so, for how long.

Cerelle may also interfere with how other medicines work, causing either an increase in effect (e.g. medicines containing ciclosporine) or a decrease in effect.

Ask your doctor or pharmacist for advice before taking any medicine.

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.

Pregnancy

Do not use Cerelle if you are pregnant, or think you may be pregnant.

Breast-feeding

Cerelle may be used while you are breast-feeding. Cerelle does not appear to influence the production or the quality of breast milk. However, there have been infrequent reports of a decrease in breast milk production while using Cerelle. A small amount of the active substance of Cerelle passes over into the milk. The health of children breast-fed for 7 months whose mothers were using desogestrel has been studied up to 2.5 years of age. No effects on the growth and development of the children were observed.

If you are breast- feeding and want to use Cerelle, please contact your doctor.

Driving and using machines

Cerelle has no influence on the ability to drive and use machines.

Cerelle contains lactose

If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.

Regular check-ups

When you are using Cerelle, your doctor will tell you to return for regular check-ups. In general, the frequency and nature of these check-ups will depend on your personal situation. PACKAGE LEAFLET: INFORMATION FOR THE USER

CERELLE®

75 microgram film-coated tablets

desogestrel

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet. You may need to read it again. – If you have any further questions, ask your doctor or pharmacist. – This medicine has been prescribed for you only. Do not pass it on to others. It may harm them. – If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

    Contact your doctor as soon as possible if:

    • you have severe pain or swelling in either of your legs, unexplained pains in the chest, breathlessness, an unusual cough, especially when you cough up blood (possibly indicating a thrombosis);
    • you have a sudden, severe stomach ache or jaundice (you may notice yellowing of the skin, the whites of the eyes, or dark urine, possibly indicating liver problems); – you feel a lump in your breast (possibly indicating breast cancer);
    • you have a sudden or severe pain in the lower abdomen or stomach area (possibly indicating an ectopic pregnancy, this is a pregnancy outside the womb); – you are to be immobilised or are to have surgery (consult your doctor at least four weeks in advance); – you have unusual, heavy vaginal bleeding;
    • you suspect that you are pregnant.

3. HOW TO TAKE CERELLE

Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.

Each strip of Cerelle contains 28 tablets. Arrows and the days of the week are printed on the front side of the strip, which help you take your pill correctly. Take your daily tablet at about the same time each day. Swallow each tablet whole with water.

Every time you start a new strip of Cerelle take a tablet from the top row. Don’t start with just any tablet. For example, if you start on a Wednesday, you should take the tablet from the top row marked “Wed”.

You should continue to take one tablet a day, until the strip is empty, always following the direction indicated by the arrows. By looking at the back of the strip of tablets you can easily check if you have already taken your tablet on a particular day. You may have some bleeding during the use of Cerelle (see section 4. ”Possible side effects”), but you must continue to take your tablet as normal.

When a strip is empty, you must start with a new pack of Cerelle on the next day – without interruption and without waiting for a bleeding.

Starting your first pack of Cerelle

If you are not using hormonal contraception at present (or in the past month)

Wait for your period to begin. On the first day of your period take the first Cerelle tablet. You need not take extra contraceptive precautions.

You may also start on days 2-5 of your cycle, but in that case make sure you also use an additional contraceptive method (barrier method) for the first 7 days of tablet-taking.

When changing from a combined pill, vaginal ring, or transdermal patch.

You can start taking Cerelle on the day after you take the last tablet from the present Pill pack, or on the day of removal of your vaginal ring or patch (this means no tablet-, ring- or patch-free break). If your present Pill pack also contains inactive tablets you can start Cerelle on the day after taking the last active tablet (if you are not sure which this is, ask your doctor or pharmacist). If you follow these instructions, you need not take extra contraceptive precautions.

If you have a tablet-, ring- or patch-free break:

You can also start at the latest the day following the tablet-, ring-, patch-free break, or placebo tablet interval, of your present contraceptive. If you follow these instructions, make sure you use an additional contraceptive method (barrier method) for the first 7 days of tablet-taking.

When changing from another progestogen-only pill (mini-pill). You may stop taking it any day and start taking Cerelle right away. Additional contraceptive precautions are not necessary.

When changing from an injectable or implant or a progestogen-releasing intrauterine device (IUD). Start using Cerelle when your next injection is due or on the day that your implant or your IUD is removed. Additional contraceptive precautions are not necessary.

After having a baby.

You can start Cerelle between 21 to 28 days after the birth of your baby. If you start later, make sure that during the first cycle you use an additional contraceptive method (barrier method) for the first 7 days of tablet- taking. However, if you have already had sex, check that you are not pregnant before starting Cerelle use. Additional information for breast-feeding women can be found in ‘Pregnancy and breast-feeding’ in section 2. Your doctor can also advise you.

After a miscarriage or an abortion.

Your doctor will advise you.

If you forget to take one or more tablets

If you are less than 12 hours late

Take the tablet as soon as you remember, and take the next one at the usual time. The contraceptive action of Cerelle is maintained.

If you are more than 12 hours late

If you are more than 12 hours late in taking any tablet, you may not be completely protected against pregnancy. The more consecutive tablets you have missed, the higher the risk that you might fall pregnant.

Take a tablet as soon as you remember, and take the next one at the usual time. This may mean taking two tablets on the same day. This is not harmful. (If you have forgotten more than one tablet you don’t need to take the earlier missed ones). You are not protected against pregnancy. Continue to take your tablets as usual, but you must also use an extra method, such as a condom for the next 7 days.

If you are more than 12 hours late taking your tablet and have had sex it is safe to use emergency contraception; please consult your pharmacist or doctor.

If you missed one or more tablets in the very first week of tablet-intake and had sex in the week before missing the tablets, there is a possibility of becoming pregnant. Ask your doctor for advice.

If you vomit or have diarrhoea

If you vomit within 3 - 4 hours after taking the pill or have severe diarrhoea, the active substance may not have been completely absorbed. Follow the advice for missed tablets above.

If you take more Cerelle than you should

There have been no reports on serious harmful effects from taking too many Cerelle tablets at one time. Symptoms that may occur are nausea, vomiting and, in young girls, slight vaginal bleeding. For more information ask your doctor for advice.

If you stop taking Cerelle

You can stop taking Cerelle whenever you want. From the day you stop you are no longer protected against pregnancy.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. POSSIBLE SIDE EFFECTS

Like all medicines, this medicine can cause side effects, although not everybody gets them.

You should see your doctor immediately if you experience symptoms of:

  • Allergic reactions (hypersensitivity), including swelling of the face, lips, tongue, and/or throat causing difficulty in breathing or swallowing (angioedema and/or anaphylaxis). The frequency of this side effect cannot be estimated from the available data.
  • On rare occasions, ectopic pregnancy (where the baby develops somewhere outside the womb) have been reported. If you have a sudden or severe pain in the lower abdomen or stomach area (possibly indicating an ectopic pregnancy) you should contact your doctor as soon as possible.
  • Serious undesirable effects associated with the use of Cerelle are described in section 2 “What you need to know before you take Cerelle”. Please read this section for additional information and consult your doctor at once where appropriate.
  • Vaginal bleeding may occur at irregular intervals during the use of Cerelle. This may be just slight staining which may not even require a pad, or heavier bleeding, which looks rather like a scanty period and requires sanitary protection. You may also not have any bleeding at all. These are common side effects (may affect up to 1 in 10 women). The irregular bleedings are not a sign that the contraceptive protection of Cerelle is decreased. In general, you need not take any action; just continue to take Cerelle. If, however, bleeding is heavy or prolonged you should consult your doctor.

Other side effects:

Users of desogestrel have reported the following side effects:

Common (may affect up to 1 in 10 women):

  • mood altered,
  • decreased sexual drive (libido),
  • depression,
  • headache,
  • nausea,
  • acne,
  • breast pain,
  • increased body weight.

Uncommon (may affect up to 1 in 100 women): – infection of the vagina,

  • difficulties in wearing contact lenses,
  • vomiting,
  • hair loss,
  • painful menstruation,
  • ovarian cyst,
  • tiredness.

Rare (may affect up to 1 in 1,000 women):

  • rash,
  • hives,
  • painful blue-red skin lumps (erythema nodosum) (these are skin conditions).

Not known (cannot be estimated from the available data): – tumour of the tissue surrounding the brain and spinal cord that is usually benign (meningioma).

Apart from these side effects, breast secretion may occur.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via Yellow Card Scheme. Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.By reporting side effects you can help provide more information on the safety of this medicine.

5. HOW TO STORE CERELLE

Keep this medicine out of the sight and reach of children.

Store in the original package in order to protect from light and moisture.

This medicinal product does not require any special temperature storage conditions.

Do not use this medicine after the expiry date which is stated on the carton. The expiry date refers to the last day of that month.

The active metabolite etonogestrel shows an environmental risk to fish.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. CONTENTS OF THE PACK AND OTHER INFORMATION

What Cerelle contains

  • The active substance is desogestrel. One film-coated tablet contains 75 microgram desogestrel.
  • The other ingredients are:

Tablet core:

Lactose monohydrate,

Potato starch,

Povidone K-30,

Silica, colloidal anhydrous,

Stearic acid,

all-rac- -tocopherol

Tablet coat:

Poly[vinyl alcohol],

Titanium dioxide (E171),

Macrogol 3000,

Talc

What Cerelle looks like and contents of the pack

Cerelle is white or almost white, round, biconvex film-coated tablet of about 5.5 mm in diameter, with a sign “D” on one side and “75” on the other side.

Cerelle film-coated tablets are packed in PVC/PVDC- Aluminium blister, in a laminated aluminium sachet and cardboard cartons with a leaflet and etui storing bag enclosed.

Pack sizes: 1x28, 3x28 film-coated tablets

Not all pack sizes may be marketed.

Marketing Authorisation Holder and Manufacturer

Gedeon Richter Plc.

Gyömrői út 19-21.

1103 Budapest,

Hungary

This leaflet was last revised in September 2026.

RG 0000, K-20054-2.5, 00000000

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 04854/0124

Last revision stated in the text: September 2026 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Cerelle 75 micrograms film-coated tablets

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Desogestrel
Strength 75 micrograms
Pharmaceutical form Oral tablet
White or almost white, round, biconvex film-coated tablets of about 5.5 mm in diameter,
with a sign “D” on one side and “75” on the other side.
How is it taken Oral
Excipients Lactose monohydrate,, Potato starch,, Povidone K-30,, Silica, colloidal anhydrous,, Stearic acid,, all-rac-α-tocopherol, Poly[vinyl alcohol],, Titanium dioxide (E171),, Macrogol 3000,, Talc
Pack sizes 84 tablet
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life Two years.
Storage Store in the original package in order to protect from light and moisture. This medicinal product does not require any special temperature storage conditions.
Drug group (ATC) Hormonal contraceptives for systemic use, Progestogens
  1. G Genito urinary system and sex hormones
    1. G03 Sex hormones and modulators of the genital system
      1. G03A Hormonal contraceptives for systemic use
        1. G03AC Progestogen systemic hormonal contraceptives
          1. G03AC09 desogestrel
Marketing authorisation PL 04854/0124 (first authorised 5 October 2012)
Marketing authorisation holder Gedeon Richter Plc.
Codes GTIN 5997001377147 · BNF 07030201

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.1.0 of 12 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.